Deciphering genomic underpinnings of quantitative MRI-based radiomic phenotypes of invasive breast carcinoma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhu, Yitan ^a   Li, Hui ^b   Guo, Wentian ^c   Drukker, Karen ^b   Lan, Li ^b   Giger, Maryellen L ^b   Ji, Yuan ^a,b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

BREAST TUMOR; DIAGNOSTIC IMAGING; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; HUMAN GENOME; METABOLISM; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHENOTYPE; PROCEDURES; RADIOGRAPHY; TUMOR INVASION;

BREAST NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOME, HUMAN; HUMANS; MAGNETIC RESONANCE IMAGING; MICRORNAS; MUTATION; NEOPLASM INVASIVENESS; PHENOTYPE; RADIOGRAPHY; TRANSCRIPTION, GENETIC;

EID: 84949527829     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17787     Document Type: Article

References (46)

1. Gevaert, O. et al. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data-methods and preliminary results. Radiology 264, 387-296, doi: 10.1148/radiol.12111607 (2012
2. Aerts, H. J. W. L. et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat. Commun. 5, doi: 10.1038/ncomms 5006 (2014
3. Jamshidi, N., Diehn, M., Bredel, M. & Kuo, M. D. Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. Radiology 270, 212-222, doi: 10.1148/ radiol.13130078 (2014
4. Karlo, C. A. et al. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology 270, 464-471, doi: 10.1148/radiol.13130663 (2014
5. Yamamoto, S., Maki, D. D., Korn, R. L. & Kuo, M. D. Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape. Am. J. Roentgenol. 199, 654-663, doi: 10.2214/AJR.11.7824 (2012
6. Mazurowski, M. A., Zhang, J., Grimm, L. J., Yoon, S. C. & Silber, J. I. Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. Radiology 273, 365-372, doi: 10.1148/radiol.14132641 (2014
7. Ashraf, A. B. et al. Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles. Radiology 272, 374-384, doi: 10.1148/radiol.14131375 (2014
8. Agner, S. C. et al. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study. Radiology 272, 91-99, doi: 10.1148/radiol.14121031 (2014
9. Li, H. et al. Pilot study demonstrating potential association between breast cancer image-based risk phenotypes and genomic biomarkers. Med. Phys. 41, doi: 10.1118/1.4865811 (2014
10. Li, H., Giger, M. L., Lan, L., Janardanan, J. & Sennett, C. A. Comparative analysis of image-based phenotypes of mammographic density and parenchymal patterns in distinguishing between BRCA1/2 cases, unilateral cancer cases, and controls. J. Med. Imaging 1, doi: 10.1117/1.JMI.1.3.031009 (2014
11. Gierach, G. L. et al. Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study. Breast Cancer Res. 16, 424, doi: 10.1186/s13058-014-0424-8 (2014
12. Clark, K. et al. The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J. Digit. Imaging 26, 1045-1057, doi: 10.1007/s10278-013-9622-7 (2013
13. Network, T. C. G. A. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70, doi: 10.1038/nature11412 (2012
14. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550, doi: 10.1073/pnas.0506580102 (2005
15. Varemo, L., Nielsen, J. & Nookaew, I. Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res. 41, 4378-4391, doi: 10.1093/nar/gkt111 (2013
16. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. & Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40, D109-114, doi: 10.1093/nar/gkr988 (2012
17. Mehta, C. R. & Patel, N. R. Algorithm 643. FEXACT: A Fortran subroutine for Fisher's exact test on unordered r c contingency tables. ACM Trans. Math. Softw. 12, 154-161, doi: 10.1145/6497.214326 (1986
18. Clarkson, D. B., Fan, Y. & Joe, H. A Remark on Algorithm 643: FEXACT: An Algorithm for Performing Fisher's Exact Test in r x c Contingency Tables. ACM Trans. Math. Softw. 19, 484-488, doi: 10.1145/168173.168412 (1993
19. Kanehisa, M. KEGG pathways in cancer - Homo sapiens (human), (Date of access: 18/03/2014
20. Chen, W. Computerized analysis and interpretation of breast MR images Ph.D. Thesis, The University of Chicago, (2007
21. Dutta, P. & Li, W. X. Role of the JAK-STAT Signalling Pathway in Cancer. In: eLS. doi: 10.1002/9780470015902.a0025214 (John Wiley & Sons, Ltd, 2013
22. Wagner, K. & Schmidt, J. W. The two faces of Janus kinases and their respective STATs in mammary gland development and cancer. J. Carcinog. 10, doi: 10.4103/1477-3163.90677 (2011
23. Wong, C. W., Dye, D. E. & Coombe, D. R. The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int. J. Cell Biol. 2012, doi: 10.1155/2012/340296 (2012
24. Scollen, S. et al. TGF-β Signaling Pathway and Breast Cancer Susceptibility. Cancer Epidemiol. Biomarkers Prev. 20, 1112-1119 (2011
25. Barcellos-Hoff, M. H. & Akhurst, R. J. Transforming growth factor-β in breast cancer: too much, too late. Breast Cancer Res. 11, doi: 10.1186/bcr2224 (2009
26. Spizzo, R., Nicoloso, M. S., Croce, C. M. & Calin, G. A. Snapshot: microRNAs in cancer. Cell 137, 586-586, doi: 10.1016/j. cell.2009.04.040 (2009
27. Corcoran, C., Friel, A. M., Duffy, M. J., Crown, J. & O'Driscoll, L. Intracellular and extracellular microRNAs in breast cancer. Clin. Chem. 57, 18-32 (2011
28. O'Day, E. & Lal, A. MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res. 12 (2010
29. Chen, P. S., Su, J. L. & Hung, M. C. Dysregulation of microRNAs in cancer. J. Biomed. Sci. 19, doi: 10.1186/1423-0127-19-90 (2012
30. Paredes, J. et al. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and Is associated with CDH3 promoter hypomethylation. Clin. Cancer Res. 11, 5869-5877 (2005
31. Paredes, J. et al. P-cadherin expression in breast cancer: a review. Breast Cancer Res. 9, 214, doi: 10.1186/bcr1774 (2007
32. Sabapathy, K. & Wagner, E. F. JNK2: a negative regulator of cellular proliferation. Cell Cycle 3, 1520-1523 (2004
33. Oleinik, N. V., Krupenko, N. I. & Krupenko, S. A. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway. Oncogene 26, 7222-7230 (2007
34. Kouros-Mehr, H., Slorach, E. M., Sternlicht, M. D. & Werb, Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127, 1041-1055, doi: 10.1016/j.cell.2006.09.048 (2006
35. Chou, J., Provot, S. & Werb, Z. GATA3 in development and cancer differentiation: cells GATA have it! J. Cell. Physiol. 222, 42-49, doi: 10.1002/jcp.21943 (2010
36. Curtis, C. et al. The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature 486, 346-352, doi: 10.1038/nature10983 (2012
37. Zhu, Y. Associations between genomic features and radiomic tumor phenotypes for invasive breast carcinoma, (Date of access: 08/10/2015
38. Frisch, M., Hjalgrim, H., Olsen, J. H. & Melbye, M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann. Intern. Med. 125, 815-821 (1996
39. Zhu, Y. et al. Zodiac: A Comprehensive Depiction of Genetic Interactions in Cancer by Integrating TCGA Data. JNCI-J. Natl. Cancer Inst. 107, djv129, doi: 10.1093/jnci/djv129 (2015
40. Shimauchi, A. et al. Evaluation of clinical breast MR imaging performed with prototype computer-Aided diagnosis breast MR imaging workstation: reader study. Radiology 258, 696-704, doi: 10.1148/radiol.10100409 (2011
41. Chen, W., Giger, M. L., Bick, U. & Newstead, G. M. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. Med. Phys. 33, 2878-2887 (2006
42. Chen, W., Giger, M. L., Lan, L. & Bick, U. Computerized interpretation of breast MRI: investigation of enhancement-variance dynamics. Med. Phys. 31, 1076-1082 (2004
43. Chen, W., Giger, M. L., Li, H., Bick, U. & Newstead, G. M. Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images. Magn. Reson. Med. 58, 562-571 (2007
44. Gilhuijs, K. G. A., Giger, M. L. & Bick, U. Automated analysis of breast lesions in three dimensions using dynamic magnetic resonance imaging. Med. Phys. 25, 1647-1654 (1998
45. Chen, W., Giger, M. L. & Bick, U. A fuzzy c-means (FCM)-based approach for computerized segmentation of breast lesions in dynamic contrast-enhanced MR images. Acad. Radiol. 13, 63-72 (2006
46. Zhu, Y., Qiu, P. & Ji, Y. TCGA-Assembler: open-source software for retrieving and processing TCGA data. Nat. Methods 11, 599-600 (2014